Effects of a Supratherapeutic Dose of Investigational Orally Inhaled Dihydroergotamine (MAP0004) on QT Interval: A Randomized, Double-Blind, Active- and Placebo-Controlled Crossover Study in Healthy Volunteers
Kori, Shashidhar, MD, Kellerman, Donald J., PharmD, Voloshko, Polina, MD, Haugen, Gregory, MD
Published in Clinical therapeutics (01.09.2012)
Published in Clinical therapeutics (01.09.2012)
Get full text
Journal Article
The COVID-19 pandemic and cardiovascular issues in clinical trials: Practical and regulatory issues in remote monitoring of cardiac safety
Seltzer, Jonathan, Senatore, Fortunato, Faulkner, Ken, Stein, Kenneth Martin, Browning, Lt Stephen, Voloshko, Polina, Papadopoulos, Elektra J.
Published in The American heart journal (01.01.2022)
Published in The American heart journal (01.01.2022)
Get full text
Journal Article
EFFECT OF THE DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA/GAMMA AGONIST, MURAGLITAZAR, ON CARDIAC STRUCTURE AND FUNCTION IN TYPE 2 DIABETIC PATIENTS
Rao, Vijay U, Alokozai, Dean, Voloshko, Polina, Schiller, Nelson B
Published in Journal of the American College of Cardiology (09.03.2010)
Published in Journal of the American College of Cardiology (09.03.2010)
Get full text
Journal Article